INS and type 2 diabetes mellitus: Disruption of insulin signaling, as seen in insulin resistance and type 2 diabetes mellitus, leads to impaired glucose uptake and dysregulated lipid metabolism, which contributes to metabolic dysfunction and hyperglycemia.